(Q46989472)

27 December 2017

title

Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery (English)

1 reference

27 December 2017

author

Amanda E Ramer-Tait

2

1 reference

27 December 2017

Chong Wang

6

1 reference

27 December 2017

author name string

Lucas Huntimer

1

1 reference

27 December 2017

Latrisha K Petersen

3

1 reference

27 December 2017

Kathleen A Ross

4

1 reference

27 December 2017

Katherine A Walz

5

1 reference

27 December 2017

Jesse Hostetter

7

1 reference

27 December 2017

Balaji Narasimhan

8

1 reference

27 December 2017

Michael J Wannemuehler

9

1 reference

27 December 2017

publication date

26 September 2012

1 reference

27 December 2017

Advanced Healthcare Materials

published in

1 reference

27 December 2017

volume

2

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

369-378

1 reference

27 December 2017

Vaccine adjuvants: current state and future trends

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Mechanism of action of licensed vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Vaccine adjuvants: current challenges and future approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Immunomodulatory biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Polyanhydrides: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Toxicity, biodegradation and elimination of polyanhydrides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Polymers to treat brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Polymer chemistry influences monocytic uptake of polyanhydride nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Microphase separation in bioerodible copolymers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

In vivo bioluminescence imaging for integrated studies of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

In vivo imaging of infection immunology--4I's!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Applications of bioluminescence imaging to the study of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Polyanhydrides for controlled release of bioactive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200181

21 January 2018

Identifiers

DOI

10.1002/ADHM.201200181

1 reference

27 December 2017

1 reference

27 December 2017